Global Chromosomal Microarray Analysis (CMA) Testing Market Research Report 2023

Publication ID:

PB510232607

Publication Date:

October 2, 2023

Pages:

Publisher:

MRRPB5

Countries:

Global [1]

USD 2,900.00

IT Services [2]

Computing & Electronics [3]

Description:

Chromosomal microarray analysis (CMA) is an emerging technology in the field of prenatal diagnosis. It can not only accurately detect whether the number of chromosomes and the structure of large fragments are abnormal,and it can detect microstructural variations such as microdeletions/microduplications,it has the advantages of high resolution, short detection cycle and objective results. However, CMA has certain limitations in the detection of balanced translocations, inversions, and low-level mosaicism.
The global Chromosomal Microarray Analysis (CMA) Testing market is projected to reach US$ million in 2029, increasing from US$ million in 2022, with the CAGR of % during the period of 2023 to 2029. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole Chromosomal Microarray Analysis (CMA) Testing 91制片厂.
Key companies engaged in the Chromosomal Microarray Analysis (CMA) Testing industry include Baylor Genetics, MedGenome Labs, Illumina Inc., CD Genomics, Thermo Fisher, Agilent, GeneDx, Quest Diagnostics and LabCorp, etc. Among those companies, the top 3 players guaranteed % supply worldwide in 2022.
When refers to consumption region, % value of Chromosomal Microarray Analysis (CMA) Testing were sold to North America, Europe and Asia Pacific in 2022. Moreover, China, plays a key role in the whole Chromosomal Microarray Analysis (CMA) Testing market and estimated to attract more attentions from industry insiders and investors.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2023-2029), aims to help readers to get a comprehensive understanding of global Chromosomal Microarray Analysis (CMA) Testing market with multiple angles, which provides sufficient supports to readers鈥� strategy and decision making.
By Company
Baylor Genetics
MedGenome Labs
Illumina Inc.
CD Genomics
Thermo Fisher
Agilent
GeneDx
Quest Diagnostics
LabCorp
Lineagen
Invitae
Centogene
Segment by Type
Single Nucleotide Polymorphism (SNP)
Comparative Genomic Hybridization (CGH)
Segment by Application
Medical
Laboratory
Clinical
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
The Chromosomal Microarray Analysis (CMA) Testing report covers below items:
Chapter 1: Product Basic Information (Definition, Type and Application)
Chapter 2: Global market size, regional market size. Market Opportunities and Challenges
Chapter 3: Companies鈥� Competition Patterns
Chapter 4: Product Type Analysis
Chapter 5: Product Application Analysis
Chapter 6 to 10: Country Level Value Analysis
Chapter 11: Companies鈥� Outline
Chapter 12: Market Conclusions
Chapter 13: Research Methodology and Data Source

Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.

Table Of Contents:

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Chromosomal Microarray Analysis (CMA) Testing Market Size Growth Rate by Type: 2018 VS 2022 VS 2029
1.2.2 Single Nucleotide Polymorphism (SNP)
1.2.3 Comparative Genomic Hybridization (CGH)
1.3 Market by Application
1.3.1 Global Chromosomal Microarray Analysis (CMA) Testing Market Growth by Application: 2018 VS 2022 VS 2029
1.3.2 Medical
1.3.3 Laboratory
1.3.4 Clinical
1.3.5 Others
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Chromosomal Microarray Analysis (CMA) Testing Market Perspective (2018-2029)
2.2 Chromosomal Microarray Analysis (CMA) Testing Growth Trends by Region
2.2.1 Global Chromosomal Microarray Analysis (CMA) Testing Market Size by Region: 2018 VS 2022 VS 2029
2.2.2 Chromosomal Microarray Analysis (CMA) Testing Historic Market Size by Region (2018-2023)
2.2.3 Chromosomal Microarray Analysis (CMA) Testing Forecasted Market Size by Region (2024-2029)
2.3 Chromosomal Microarray Analysis (CMA) Testing Market Dynamics
2.3.1 Chromosomal Microarray Analysis (CMA) Testing Industry Trends
2.3.2 Chromosomal Microarray Analysis (CMA) Testing Market Drivers
2.3.3 Chromosomal Microarray Analysis (CMA) Testing Market Challenges
2.3.4 Chromosomal Microarray Analysis (CMA) Testing Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Chromosomal Microarray Analysis (CMA) Testing Players by Revenue
3.1.1 Global Top Chromosomal Microarray Analysis (CMA) Testing Players by Revenue (2018-2023)
3.1.2 Global Chromosomal Microarray Analysis (CMA) Testing Revenue Market Share by Players (2018-2023)
3.2 Global Chromosomal Microarray Analysis (CMA) Testing Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Chromosomal Microarray Analysis (CMA) Testing Revenue
3.4 Global Chromosomal Microarray Analysis (CMA) Testing Market Concentration Ratio
3.4.1 Global Chromosomal Microarray Analysis (CMA) Testing Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Chromosomal Microarray Analysis (CMA) Testing Revenue in 2022
3.5 Chromosomal Microarray Analysis (CMA) Testing Key Players Head office and Area Served
3.6 Key Players Chromosomal Microarray Analysis (CMA) Testing Product Solution and Service
3.7 Date of Enter into Chromosomal Microarray Analysis (CMA) Testing Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Chromosomal Microarray Analysis (CMA) Testing Breakdown Data by Type
4.1 Global Chromosomal Microarray Analysis (CMA) Testing Historic Market Size by Type (2018-2023)
4.2 Global Chromosomal Microarray Analysis (CMA) Testing Forecasted Market Size by Type (2024-2029)
5 Chromosomal Microarray Analysis (CMA) Testing Breakdown Data by Application
5.1 Global Chromosomal Microarray Analysis (CMA) Testing Historic Market Size by Application (2018-2023)
5.2 Global Chromosomal Microarray Analysis (CMA) Testing Forecasted Market Size by Application (2024-2029)
6 North America
6.1 North America Chromosomal Microarray Analysis (CMA) Testing Market Size (2018-2029)
6.2 North America Chromosomal Microarray Analysis (CMA) Testing Market Growth Rate by Country: 2018 VS 2022 VS 2029
6.3 North America Chromosomal Microarray Analysis (CMA) Testing Market Size by Country (2018-2023)
6.4 North America Chromosomal Microarray Analysis (CMA) Testing Market Size by Country (2024-2029)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Chromosomal Microarray Analysis (CMA) Testing Market Size (2018-2029)
7.2 Europe Chromosomal Microarray Analysis (CMA) Testing Market Growth Rate by Country: 2018 VS 2022 VS 2029
7.3 Europe Chromosomal Microarray Analysis (CMA) Testing Market Size by Country (2018-2023)
7.4 Europe Chromosomal Microarray Analysis (CMA) Testing Market Size by Country (2024-2029)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Chromosomal Microarray Analysis (CMA) Testing Market Size (2018-2029)
8.2 Asia-Pacific Chromosomal Microarray Analysis (CMA) Testing Market Growth Rate by Region: 2018 VS 2022 VS 2029
8.3 Asia-Pacific Chromosomal Microarray Analysis (CMA) Testing Market Size by Region (2018-2023)
8.4 Asia-Pacific Chromosomal Microarray Analysis (CMA) Testing Market Size by Region (2024-2029)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Chromosomal Microarray Analysis (CMA) Testing Market Size (2018-2029)
9.2 Latin America Chromosomal Microarray Analysis (CMA) Testing Market Growth Rate by Country: 2018 VS 2022 VS 2029
9.3 Latin America Chromosomal Microarray Analysis (CMA) Testing Market Size by Country (2018-2023)
9.4 Latin America Chromosomal Microarray Analysis (CMA) Testing Market Size by Country (2024-2029)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Chromosomal Microarray Analysis (CMA) Testing Market Size (2018-2029)
10.2 Middle East & Africa Chromosomal Microarray Analysis (CMA) Testing Market Growth Rate by Country: 2018 VS 2022 VS 2029
10.3 Middle East & Africa Chromosomal Microarray Analysis (CMA) Testing Market Size by Country (2018-2023)
10.4 Middle East & Africa Chromosomal Microarray Analysis (CMA) Testing Market Size by Country (2024-2029)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Baylor Genetics
11.1.1 Baylor Genetics Company Detail
11.1.2 Baylor Genetics Business Overview
11.1.3 Baylor Genetics Chromosomal Microarray Analysis (CMA) Testing Introduction
11.1.4 Baylor Genetics Revenue in Chromosomal Microarray Analysis (CMA) Testing Business (2018-2023)
11.1.5 Baylor Genetics Recent Development
11.2 MedGenome Labs
11.2.1 MedGenome Labs Company Detail
11.2.2 MedGenome Labs Business Overview
11.2.3 MedGenome Labs Chromosomal Microarray Analysis (CMA) Testing Introduction
11.2.4 MedGenome Labs Revenue in Chromosomal Microarray Analysis (CMA) Testing Business (2018-2023)
11.2.5 MedGenome Labs Recent Development
11.3 Illumina Inc.
11.3.1 Illumina Inc. Company Detail
11.3.2 Illumina Inc. Business Overview
11.3.3 Illumina Inc. Chromosomal Microarray Analysis (CMA) Testing Introduction
11.3.4 Illumina Inc. Revenue in Chromosomal Microarray Analysis (CMA) Testing Business (2018-2023)
11.3.5 Illumina Inc. Recent Development
11.4 CD Genomics
11.4.1 CD Genomics Company Detail
11.4.2 CD Genomics Business Overview
11.4.3 CD Genomics Chromosomal Microarray Analysis (CMA) Testing Introduction
11.4.4 CD Genomics Revenue in Chromosomal Microarray Analysis (CMA) Testing Business (2018-2023)
11.4.5 CD Genomics Recent Development
11.5 Thermo Fisher
11.5.1 Thermo Fisher Company Detail
11.5.2 Thermo Fisher Business Overview
11.5.3 Thermo Fisher Chromosomal Microarray Analysis (CMA) Testing Introduction
11.5.4 Thermo Fisher Revenue in Chromosomal Microarray Analysis (CMA) Testing Business (2018-2023)
11.5.5 Thermo Fisher Recent Development
11.6 Agilent
11.6.1 Agilent Company Detail
11.6.2 Agilent Business Overview
11.6.3 Agilent Chromosomal Microarray Analysis (CMA) Testing Introduction
11.6.4 Agilent Revenue in Chromosomal Microarray Analysis (CMA) Testing Business (2018-2023)
11.6.5 Agilent Recent Development
11.7 GeneDx
11.7.1 GeneDx Company Detail
11.7.2 GeneDx Business Overview
11.7.3 GeneDx Chromosomal Microarray Analysis (CMA) Testing Introduction
11.7.4 GeneDx Revenue in Chromosomal Microarray Analysis (CMA) Testing Business (2018-2023)
11.7.5 GeneDx Recent Development
11.8 Quest Diagnostics
11.8.1 Quest Diagnostics Company Detail
11.8.2 Quest Diagnostics Business Overview
11.8.3 Quest Diagnostics Chromosomal Microarray Analysis (CMA) Testing Introduction
11.8.4 Quest Diagnostics Revenue in Chromosomal Microarray Analysis (CMA) Testing Business (2018-2023)
11.8.5 Quest Diagnostics Recent Development
11.9 LabCorp
11.9.1 LabCorp Company Detail
11.9.2 LabCorp Business Overview
11.9.3 LabCorp Chromosomal Microarray Analysis (CMA) Testing Introduction
11.9.4 LabCorp Revenue in Chromosomal Microarray Analysis (CMA) Testing Business (2018-2023)
11.9.5 LabCorp Recent Development
11.10 Lineagen
11.10.1 Lineagen Company Detail
11.10.2 Lineagen Business Overview
11.10.3 Lineagen Chromosomal Microarray Analysis (CMA) Testing Introduction
11.10.4 Lineagen Revenue in Chromosomal Microarray Analysis (CMA) Testing Business (2018-2023)
11.10.5 Lineagen Recent Development
11.11 Invitae
11.11.1 Invitae Company Detail
11.11.2 Invitae Business Overview
11.11.3 Invitae Chromosomal Microarray Analysis (CMA) Testing Introduction
11.11.4 Invitae Revenue in Chromosomal Microarray Analysis (CMA) Testing Business (2018-2023)
11.11.5 Invitae Recent Development
11.12 Centogene
11.12.1 Centogene Company Detail
11.12.2 Centogene Business Overview
11.12.3 Centogene Chromosomal Microarray Analysis (CMA) Testing Introduction
11.12.4 Centogene Revenue in Chromosomal Microarray Analysis (CMA) Testing Business (2018-2023)
11.12.5 Centogene Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

Companies Mentioned:

Baylor Genetics
MedGenome Labs
Illumina Inc.
CD Genomics
Thermo Fisher
Agilent
GeneDx
Quest Diagnostics
LabCorp
Lineagen
Invitae
Centogene

License Types:

Single User License (PDF)

This license allows for use of a publication by one person.
This person may print out a single copy of the publication.
This person can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
This person cannot share the publication (or any information contained therein) with any other person or persons.
Unless a Enterprise License is purchased, a Single User License must be purchased for every person that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Site License (PDF)*

This license allows for use of a publication by all users within one corporate location, e.g. a regional office.
These users may print out a single copy of the publication.
These users can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
These users cannot share the publication (or any information contained therein) with any other person or persons outside the corporate location for which the publication is purchased.
Unless a Enterprise License is purchased, a Site User License must be purchased for every corporate location by an organization that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Global License (PDF)*

This license allows for use of a publication by unlimited users within the purchasing organization e.g. all employees of a single company.
Each of these people may use the publication on any computer, and may print out the report, but may not share the publication (or any information contained therein) with any other person or persons outside of the organization.
These employees of purchasing organization can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.

*If Applicable.